Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy

Rheumatoid arthritis (RA) is an autoimmune disease characterized by severe synovial inflammation and cartilage damage. Despite great progress in RA therapy, there still lacks the drugs to completely cure RA patients. Herein, we propose a reprogrammed neutrophil cytopharmaceuticals loading with TNFα-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yijun, Li, Kaiming, Jiao, Mengying, Huang, Yingshuang, Zhang, Zihao, Xue, Lingjing, Ju, Caoyun, Zhang, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978920/
https://www.ncbi.nlm.nih.gov/pubmed/36873164
http://dx.doi.org/10.1016/j.apsb.2022.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978920/
https://www.ncbi.nlm.nih.gov/pubmed/36873164
http://dx.doi.org/10.1016/j.apsb.2022.08.012

Ejemplares similares